Here are three stocks with continued technical momentum in the days and weeks after strong earnings releases.
Clovis Oncology, Inc. (CLVS) jumped 75 cents to $7.76 on 8.1 million shares Thursday. The move continued the stock’s run-up following the biotech company’s better-than-expected earnings release two weeks ago. The stock closed right above lateral resistance, and next target is the rising channel top near $9-9.25.
(more…)